Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
302
NCT00040573
Safety and Tolerability Study of 131I-TM-601 to Treat Adult Patients With Recurrent Glioma.
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2002
Completion: Aug 31, 2003
NCT00114309
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Phase: Phase 2
Start: Nov 30, 2004
Completion: Aug 31, 2009
NCT00379132
131-I-TM-601 Study in Adults With Solid Tumors
Phase: Phase 1
Start: Aug 31, 2006
Completion: Aug 31, 2008
NCT00591058
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
Start: Feb 29, 2008
Completion: Feb 28, 2010
NCT00683761
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
Start: Aug 31, 2008
Completion: Apr 30, 2010